We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Repeated successful use of eltrombopag in chronic primary immune thrombocytopenia: description of an intriguing case.
- Authors
Santoro, Cristina; Volpicelli, Paola; Baldacci, Erminia; Ferrara, Grazia; Di Rocco, Alice; Ferretti, Antonietta; Porrazzo, Marika; Mazzucconi, Maria Gabriella
- Abstract
Key Clinical Message Thrombopoietin receptor agonists ( TPO- RAs) are used as effective alternative treatments in ITP patients unresponsive to first-/second-line therapies. TPO- RAs can also be used to normalize platelet count to safely perform invasive procedures and chemotherapy, in case of malignancies. In few responsive patients, TPO- RAs can be suspended maintaining a sustained response.
- Subjects
ELTROMBOPAG; IDIOPATHIC thrombocytopenic purpura; PLATELET count; CANCER chemotherapy; AUTOIMMUNE disease treatment; THERAPEUTICS
- Publication
Clinical Case Reports, 2017, Vol 5, Issue 8, p1385
- ISSN
2050-0904
- Publication type
Article
- DOI
10.1002/ccr3.920